|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.270 CNY | -3.82% |
|
-10.66% | -27.65% |
| Market Cap | 2.24B 330M 292M 271M 249M 466M 31.9B 473M 3.22B 1.26B 15.69B 1.24B 1.21B 54.11B | P/E 2024 |
-2.74x | P/E 2025 | -7.41x |
|---|---|---|---|---|---|
| Enterprise Value | 2.65B 391M 345M 321M 294M 551M 37.77B 560M 3.81B 1.49B 18.57B 1.47B 1.44B 64.07B | EV / Sales 2024 |
2.87x | EV / Sales 2025 | 3.89x |
| Free-Float |
54.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.82% | ||
| 1 week | -10.66% | ||
| Current month | -2.39% | ||
| 1 month | -9.17% | ||
| 3 months | -30.57% | ||
| 6 months | -24.83% | ||
| Current year | -27.65% |
| 1 week | 3.18 | 3.6 | |
| 1 month | 3.18 | 3.88 | |
| Current year | 3.18 | 5.26 | |
| 1 year | 3.18 | 6.09 | |
| 3 years | 1.24 | 6.09 | |
| 5 years | 1.24 | 7.83 | |
| 10 years | 1.24 | 31.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Zhang
CEO | Chief Executive Officer | 59 | 2010-02-28 |
| Director of Finance/CFO | 52 | 2023-04-20 | |
Wei He
CTO | Chief Tech/Sci/R&D Officer | 49 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yun Xie
BRD | Director/Board Member | 54 | 2017-03-15 |
Xiao You Zhang
BRD | Director/Board Member | 74 | - |
Zhi Qiang Zhang
BRD | Director/Board Member | 59 | 2010-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.82% | -10.66% | -33.27% | -17.01% | 343M | ||
| +0.86% | +2.30% | +49.71% | +158.86% | 1,057B | ||
| +1.59% | +5.37% | +55.77% | +54.77% | 624B | ||
| +0.95% | +1.95% | +36.11% | +80.44% | 454B | ||
| +1.60% | +7.09% | +35.90% | +29.32% | 341B | ||
| -0.60% | +2.95% | +36.28% | +39.04% | 297B | ||
| -0.14% | +0.33% | +18.70% | +17.64% | 262B | ||
| +0.09% | -4.53% | -27.60% | -42.19% | 215B | ||
| +1.22% | +1.20% | +21.61% | +60.14% | 201B | ||
| -1.18% | -5.13% | +13.87% | +60.35% | 162B | ||
| Average | -0.22% | +0.31% | +20.71% | +44.14% | 361.43B | |
| Weighted average by Cap. | +0.04% | +1.57% | +36.61% | +76.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.2B 177M 156M 145M 133M 249M 17.05B 253M 1.72B 674M 8.38B 663M 649M 28.92B | 900M 133M 117M 109M 100M 187M 12.83B 190M 1.3B 507M 6.31B 499M 488M 21.77B |
| Net income | -650M -96.01M -84.72M -78.76M -72.28M -135M -9.27B -138M -936M -367M -4.56B -360M -353M -15.73B | -420M -61.98M -54.69M -50.84M -46.66M -87.36M -5.98B -88.81M -604M -237M -2.94B -233M -228M -10.15B |
| Net Debt | 1.66B 245M 217M 201M 185M 346M 23.69B 352M 2.39B 937M 11.65B 921M 901M 40.19B | 412M 60.79M 53.64M 49.86M 45.76M 85.68M 5.87B 87.1M 593M 232M 2.89B 228M 223M 9.96B |
Employees
979
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | CN¥3.270 | -3.82% | 6,576,200 |
| 26-07-23 | CN¥3.400 | +3.66% | 8,028,936 |
| 26-07-22 | CN¥3.280 | -0.91% | 8,775,400 |
| 26-07-21 | CN¥3.310 | -2.65% | 11,925,500 |
| 26-07-20 | CN¥3.400 | -2.30% | 12,977,100 |
- Stock Market
- Stocks
- 002742 Stock
Select your edition
All financial news and data tailored to specific country editions
















